ANO1 and prostate cancer: For instance, research shows that the levels of TMEM16A mRNA and protein are significantly elevated in metastatic prostate cancer cell lines, including LNCaP and PC-3, as confirmed by quantitative PCR, Western blotting, and patch clamp assays (Liu et al., 2012).